Investment Analysts’ Recent Ratings Changes for Solid Biosciences (SLDB)

A number of research firms have changed their ratings and price targets for Solid Biosciences (NASDAQ: SLDB): 12/13/2024 – Solid Biosciences is now covered by analysts at Wedbush. They set an “outperform” rating and a $16.00 price target on the stock. 12/12/2024 – Solid Biosciences was upgraded by analysts at Wedbush to a “strong-buy” rating. […]

Leave a Reply

Your email address will not be published.

Previous post Identillect Technologies (CVE:ID) Trading Down 50% – Should You Sell?
Next post Tamboran Resources Corp (NYSE:TBN) Short Interest Down 14.7% in December